Opinion: Can we eliminate hepatitis?

Thursday is World Hepatitis Day, an occasion to celebrate the strides in treating and – lo and behold – curing those who suffer from hepatitis C.

With advancements in therapies, not only are we curing the disease, global elimination is now possible. On May 28, close to 200 member countries of the World Health Organization, including Canada, made a historic pledge to eliminate viral hepatitis by 2030. If governments remain committed, we will witness one of the greatest current global public health threats eliminated in our lifetime.

The HCV virus has been a scourge. A recent study by the United States Centers for Disease Control (CDC) found annual hepatitis C-related mortality in 2013 surpassed the total combined deaths from 60 other reported infectious diseases including HIV, pneumococcal disease and tuberculosis.

The group most impacted – some 60,000 in B.C. – are baby boomers born from 1945 to 1975. Many have lived with the infection for many years but have not gone for testing because they do not believe themselves at risk.

The hep C virus can cause damage for decades without symptoms and can lead to liver cancer, irreversible liver failure as well as neurological and gastrointestinal issues.

A new study this year by the B.C. Centre for Excellence in HIV/AIDS and the CDC found peak infection for baby boomers occurred in those who were aged five in 1950, infected by inadequately sterilized needles used in health care settings. This data proved inaccurate earlier assumptions that those most at risk were ’60s-era young people who engaged in high-risk sex or drug use.

The good news is, oral medications available since 2014 make elimination of hepatitis C an increasingly achievable goal. These drugs represent a huge leap forward in combating this disease for thousands of people, including me. Treatments can take less than three months for cure rates approaching 100 per cent with minimal side effects.

The journey from disease discovery to cure has been surprisingly short.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below